MTHFR and Addiction: Why Some People Are Wired to Be More Vulnerable

Addiction is one of the most misunderstood areas of human health. The standard narrative centres on willpower, moral failure, and personal weakness. But the science tells a different story — one of genetics, neurobiology, and the deep vulnerability of certain brains to the pull of substance use.

For a significant proportion of people who struggle with addiction, the root of that vulnerability lies in the methylation cycle and its downstream effects on dopamine, serotonin, and the brain's capacity to experience reward.

The Neurobiological Reality

MTHFR variants are found at elevated rates across multiple addiction populations. The mechanisms are well-understood: impaired dopamine synthesis from reduced methylation capacity, elevated homocysteine dysregulating NMDA receptors and disrupting reward signalling, reduced SAM affecting neurotransmitter methylation, and neuroinflammation creating a chronically destabilised neurochemical environment. For people with fast COMT, substances that spike dopamine feel genuinely corrective — filling a neurochemical gap the brain cannot fill independently. This is self-medication in the most literal sense.

The Recovery Piece

Many of the symptoms that make recovery most difficult — persistent anxiety, insomnia, depression, cognitive fog, mood instability, cravings — are downstream of methylation insufficiency compounded by the B vitamin depletion that alcohol and other substances cause. Addressing this nutritionally removes a biological obstacle that makes every other aspect of recovery harder. It doesn't replace professional support. It makes professional support more effective.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you are in recovery or struggling with addiction, please seek support from qualified healthcare professionals and addiction services.